Why Has Model-Informed Precision Dosing Not Yet Become Common Clinical Reality? Lessons From the Past and a Roadmap for the Future-Reference-Cited by-同舟云学术

Why Has Model-Informed Precision Dosing Not Yet Become Common Clinical Reality? Lessons From the Past and a Roadmap for the Future

Published:2017-04-04 Issue:5 Volume:101 Page:646-656
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Darwich A S¹,Ogungbenro K¹,Vinks A A²³,Powell J R⁴,Reny J-L⁵⁶,Marsousi N⁷,Daali Y⁵⁷,Fairman D⁸,Cook J⁹,Lesko L J¹⁰,McCune J S¹¹,Knibbe C A J¹²,de Wildt S N¹³¹⁴,Leeder J S¹⁵¹⁶,Neely M¹⁷,Zuppa A F¹⁸,Vicini P¹⁹,Aarons L¹,Johnson T N²⁰,Boiani J²¹,Rostami-Hodjegan A¹²¹

Affiliation:

1. Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry; University of Manchester; Manchester UK

2. Cincinnati Children's Hospital Medical Center; Cincinnati Ohio USA

3. Department of Pediatrics; University of Cincinnati School of medicine; Cincinnati Ohio USA

4. Eshelman School of Pharmacy; University of North Carolina; Chapel Hill North Carolina USA

5. Geneva Platelet Group, School of Medicine; University of Geneva; Geneva Switzerland

6. Department of Internal Medicine, Rehabilitation and Geriatrics; Geneva University Hospitals; Geneva Switzerland

7. Clinical Pharmacology and Toxicology; Geneva University Hospitals; Geneva Switzerland

8. Clinical Pharmacology Modeling and Simulation, GSK Stevenage; UK

9. Clinical Pharmacology, Pfizer Inc; Groton Connecticut USA

10. Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology; University of Florida at Lake Nona (Orlando); Orlando Florida USA

11. University of Washington Department of Pharmaceutics and Fred Hitchinson Cancer Research Center Clinical Research Division; Seattle Washington USA

12. Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, the Netherlands and Division of Pharmacology, Leiden Academic Centre for Drug Research; Leiden University; the Netherlands

13. Department of Pharmacology and Toxicology; Radboud University; Nijmegen the Netherlands

14. Intensive Care and Department of Pediatric Surgery, Erasmus MC Sophia Children's Hospital; Rotterdam the Netherlands

15. Division of Pediatric Pharmacology and Medical Toxicology, Department of Pediatrics, Children's Mercy Hospitals and Clinics; Kansas City Missouri USA

16. Department of Pharmacology; University of Missouri-Kansas City; Kansas City Missouri USA

17. University of Southern California and the Children's Hospital of Los Angeles; Los Angeles California USA

18. Children's Hospital of Philadelphia; Philadelphia Pennsylvania USA

19. Clinical Pharmacology, Pharmacometrics and DMPK, MedImmune; Cambridge UK

20. Certara, Blades Enterprise Centre; Sheffield UK

21. Epstein Becker & Green; Washington DC USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference75 articles.

1. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Hirsh;Chest,2004

2. AGenentech TAMIFLU(R) (Oseltamivir Phosphate) Capsules, for Oral Suspension: Highlights of Prescribing Information

3. N. Developing a paediatric drug formulary for the Netherlands;Zanden;Arch. Dis. Child.,2016

4. NKFK Kinderformularium - Vancomycine https://www.kinderformularium.nl/geneesmiddel/337/vancomycine 2016

5. ARoche CYTOVENE(R)-IV (ganciclovir sodium for injection): Prescribing information

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A User‐Driven Framework for Dose Selection in Pregnancy: Proof of Concept for Sertraline;Clinical Pharmacology & Therapeutics;2024-09-09

2. Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape;Drugs;2024-09-06

3. Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations;European Journal of Pharmaceutical Sciences;2024-09

4. Willingness-to-use and preferences for model-informed antenatal doses: a cross-sectional study among European healthcare practitioners and pregnant women;Frontiers in Pharmacology;2024-08-15

5. A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease;Journal of Pharmacy and Pharmacology;2024-07-15